Citation:Holmström B, Holmberg E, Egevad L, Adolfsson J, Johansson JE, Hugosson J, et al 2010

From Cancer Guidelines Wiki

Citation


Holmström B, Holmberg E, Egevad L, Adolfsson J, Johansson JE, Hugosson J, et al. Outcome of primary versus deferred radical prostatectomy in the National Prostate Cancer Register of Sweden Follow-Up Study. J Urol 2010 Oct;184(4):1322-7 Available from: http://www.ncbi.nlm.nih.gov/pubmed/20723940.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Holmström B, Holmberg E, Egevad L, Adolfsson J, Johansson JE, Hugosson J, et al 2010For men with biopsy-diagnosed prostate cancer, for which patients (based on diagnostic and clinical criteria) does active surveillance achieve equivalent or better outcomes in terms of length and quality of life than definitive treatment?Katherine Sheridancompleted
Holmström B, Holmberg E, Egevad L, Adolfsson J, Johansson JE, Hugosson J, et al 2010 2For men with biopsy-diagnosed prostate cancer, for which patients (based on diagnostic and clinical criteria) does active surveillance achieve equivalent or better outcomes in terms of length and quality of life than definitive treatment?Dr Albert Chetcuti BTech(Biotech) Hons, PhDcompleted
Holmström B, Holmberg E, Egevad L, Adolfsson J, Johansson JE, Hugosson J, et al 2010 4For men with biopsy-diagnosed prostate cancer, for which patients (based on diagnostic and clinical criteria) does active surveillance achieve equivalent or better outcomes in terms of length and quality of life than definitive treatment?Dr. med. univ. Dana Stefanoviccompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:For men with biopsy-diagnosed prostate cancer, for which patients does active surveillance achieve equivalent or better outcomes in terms of length and quality of life than definitive treatment?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:For men with biopsy-diagnosed prostate cancer, for which patients does active surveillance achieve equivalent or better outcomes in terms of length and quality of life than definitive treatment?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:For men with biopsy-diagnosed prostate cancer, for which patients does active surveillance achieve equivalent or better outcomes in terms of length and quality of life than definitive treatment?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:For men with biopsy-diagnosed prostate cancer, for which patients does active surveillance achieve equivalent or better outcomes in terms of length and quality of life than definitive treatment?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:For men with biopsy-diagnosed prostate cancer, for which patients does active surveillance achieve equivalent or better outcomes in terms of length and quality of life than definitive treatment?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:For men with biopsy-diagnosed prostate cancer, for which patients does active surveillance achieve equivalent or better outcomes in terms of length and quality of life than definitive treatment?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. Active surveillance
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:Holmström_B,_Holmberg_E,_Egevad_L,_Adolfsson_J,_Johansson_JE,_Hugosson_J,_et_al_2010&oldid=70600"